Systematic review of economic analyses of health care-associated infections

Stone, Patricia W.; Braccia, Deborah; Larson, Elaine

doi:10.1016/j.ajic.2005.04.246

Cited by 293 publications

(201 citation statements)

References 43 publications

Supporting

Mentioning

159

Contrasting

Unclassified

Order By: Relevance

“…Existen diferentes estrategias de estimación de los costos de la atención de los pacientes con infecciones (12,(14)(15)(16)(17). Sin embargo, nuestro sistema de salud aún no cuenta con bases de datos y sistemas contables comparables que faciliten el uso de las técnicas reconocidas como las más apropiadas, por ejemplo, la herramienta razón costo-factura (charge to cost ratio) empleada en Norteamérica (31).…”

Section: Discussionunclassified

“…Un número creciente de estudios plantea que las infecciones del torrente sanguíneo son uno de los tipos de infección cuya atención demanda más recursos económicos (10)(11)(12)(13), lo que subraya la necesidad de conocer las implicaciones econó-micas de este fenómeno en nuestro medio, especialmente las relacionadas con S. aureus resistente a la meticilina (SARM).…”

unclassified

“…Existen varios métodos para determinar el efecto económico de la resistencia, lo cual origina estimaciones heterogéneas, adaptadas exclusivamente al contexto del que provienen (12,(14)(15)(16)(17). Hay reportes de incrementos entre 1,3 y 2 veces en los costos de atención cuando se comparan pacientes infectados por S. aureus resistente a la meticilina con pacientes con S. aureus sensible a dicho medicamento (18).…”

unclassified

See 2 more Smart Citations

Impacto económico de la resistencia a meticilina en pacientes con bacteriemia por Staphylococcus aureus en hospitales de Bogotá

et al. 2014

View full text Add to dashboard Cite

Section: Discussionunclassified

unclassified

See 1 more Smart Citation

Impacto económico de la resistencia a meticilina en pacientes con bacteriemia por Staphylococcus aureus en hospitales de Bogotá

et al. 2014

View full text Add to dashboard Cite

“…HAIs rank as the fifth leading cause of death in acute care hospitals and account for approximately 88,000 deaths annually in the United States 5,24 . The incidence of HAI has increased 36% from 1975 to 1995, indicating that many challenges still exist in prevention and control of HAI 11,32,35 . Healthcare expenditures have experienced double digit growth over the past three decades, with incremental costs of HAI playing a significant role in the decisions of health care managers 31 .…”

Section: Introductionmentioning

confidence: 99%

Clinical and economic analysis of hospital acquired infections in patients diagnosed with brain tumor in a tertiary hospital

Undabeitia¹,

Liu²,

Catalan³

et al. 2011

Neurocirugía

View full text Add to dashboard Cite

SummaryObjectives. To analyze the relationship between hospital acquired infections and clinical outcomes, duration of stay, and cost per infectious episode in patients diagnosed with brain tumors in our service.Materials and methods. We conducted a retrospective study on patients diagnosed with brain tumors and admitted to the department of neurosurgery in the Cruces Hospital of the University of the Basque Country between January 1st, 2007 and December 31st, 2007. We collected demographics, responsible pathogens, infection location, length of hospitalization, and costs of various medical and surgical procedures performed.Results. We reviewed 139 patients that accumulated 210 hospital visits. We found 34 episodes of hospital acquired infections (16.25% of patients). The most frequent infections were that of the lower respiratory tract, urinary tract, and surgical site. We found that patients with HAIs had a significantly lower final KPS score (sig <0.01), greater mean cost of stay (17097€, sig.<0.01), and longer length of stay (15.45 days, sig<0.01). We did not find a significant difference in mortality.Conclusions. We found significant association between the presence of HAIs and worse clinical outcomes, higher costs, and longer length of stay. The pathogens responsible and infection locations were similar to existing series in the literature. Although variability in study designs in the literature makes interpretation and comparison of results difficult, measures to prevent these complications can improve quality of care and reduce costs.KEY WORDS. Brain neoplasms. Infection. Costs. Análisis clínico económico de las infecciones nosocomiales en los pacientes diagnosticados de tumoración cerebral en un hospital terciario ResumenObjetivos. Analizar la relación entre la presencia de infección nosocomial y el resultado clínico final, la duración de la estancia y el coste del episodio en los pacientes diagnosticados de tumoración cerebral en nuestro servicio. Material y método. Realizamos un estudio retrospectivo incluyendo los pacientes ingresados en el Servicio de Neurocirugía del Hospital Universitario de Cruces con diagnostico de tumoración cerebral en el periodo comprendido entre el 1-1-2007 y el 31-12 del 2007. Recogimos variables demográficas, los microorganismos responsables y la localización de las distintas infecciones, el tiempo de ingreso y los costes de los distintos procedimientos médicos y quirúrgicos realizados.Resultados. Recogimos 139 pacientes, que acumularon un total de 210 episodios. Encontramos la presencia de infecciones nosocomiales en 34 episodios (16,25%). La localización mas frecuente fue la respiratoria, seguida del tracto urinario y la infección de herida quirúr-gica. Encontramos unas diferencias significativas en la situación funcional al alta (sig <0.01), el coste medio de los episodios (17097€, sig.<0.01) y en la estancia media (15.45 días, sig.<0.01). No encontramos diferencias significativas con respecto a la mortalidad.Conclusiones. Encontramos asociaciones significativas entre la...

show abstract

“…7 The annual economic impact of HCAI in the USA was approximately US$ 6.5 billion in 2004. 15 In the USA, similar to the position in other industrialized countries, the most frequent type of infection hospitalwide is urinary tract infection (UTI) (36%), followed by surgical site infection (SSI) (20%), bloodstream infection (BSI), and pneumonia (both 11%). 7 It is noteworthy, however, that some infection types such as BSI and ventilator-associated pneumonia have a more severe impact than others in terms of mortality and extra-costs.…”

Section: Health Care-associated Infection In Developed Countriesmentioning

confidence: 99%